James B. Renacci sold Alexion Pharmaceuticals (ALXN) (ALXN)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 32 trades in Alexion Pharmaceuticals (ALXN) (ALXN) since 2013, 14 purchases and 18 sales, worth an estimated $464K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: James B. Renacci sold $1,000 - $15,000 of Alexion Pharmaceuticals (ALXN) (ALXN) on July 16, 2014. Since that trade, ALXN is up +0.00% against the S&P 500 up +349.52%, an outperformance of -349.52%.
Across these filings, James B. Renacci has been a net seller of ALXN (a buy-to-sell ratio of 0.78). The most recent disclosed ALXN transaction shown was dated June 20, 2016. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
James B. Renacci's ALXN trades vs the price
ALXN is up +0.00% since James B. Renacci sold on July 16, 2014, versus +349.52% for the S&P 500.
Performance since this trade
All James B. Renacci ALXN trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
James B. Renacci & ALXN trading FAQ
Is it legal for James B. Renacci to trade Alexion Pharmaceuticals (ALXN) (ALXN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Alexion Pharmaceuticals (ALXN) (ALXN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci sell ALXN?
James B. Renacci disclosed a sale of $1,000 - $15,000 of Alexion Pharmaceuticals (ALXN) (ALXN) on July 16, 2014, according to public STOCK Act filings.
How has ALXN performed since James B. Renacci's trade?
Since James B. Renacci sold ALXN on July 16, 2014, the stock is up +0.00%, versus +349.52% for the S&P 500 over the same period, an outperformance of -349.52%.
How many times has James B. Renacci traded ALXN?
James B. Renacci has disclosed 32 ALXN trades since 2013 (14 purchases and 18 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ALXN trades?
Quantellect tracks every disclosed congressional trade in Alexion Pharmaceuticals (ALXN) (ALXN) on the Alexion Pharmaceuticals (ALXN) congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's ALXN tradesAll congressional filings for Alexion Pharmaceuticals (ALXN)James B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.